Shandi, an alternative protein company based in Singapore, announced this week in a press release sent to The Spoon that it has raised $700,000 USD in a second seed round. The round was led by Tolaram, and also saw participation from SparkLabs Cultiv8 and other private investors.
This new influx of capital will allow Shandi to build out a production facility in Singapore, as well as scale and commercialize its alternative protein products. Additionally, the company will focus on innovating new products and developing partnerships in the food sector.
Shandi’s offerings include various chicken analogs, including shreds, pieces, strips, and drumsticks. All of the products are made with a combination of non-GMO chickpeas, pea protein, quinoa, flax seeds, brown rice, and coconut oil. The company has not disclosed much about its production process, but it does have a pending patent for its technology involving the extraction of amino acids from various plants. This process is used to replicate the amino acid profile found in chicken to provide a similar nutritional composition and flavor.
Alternative chicken has popped up nonstop in the news during the past few months. Chicken is one of the most consumed meats in the world, and recently, there have been global supply chain shortages of it. Plant-based chicken could offer a solution for filling in these shortages. Shandi is another example of an alternative protein company opening a production facility in Singapore. Avant Meats, Perfect Day, and Next Gen are just a few other alternative protein start-ups that have built out production facilities in the city-state.
Shandi aims to launch a range of products during the first quarter of 2022 in foodservice channels. After this, it plans on releasing a B2C product.